MedRx Co., Ltd (4586.T)
Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Yonehiro Matsumura | President, CEO & Representative Director | -- | -- | 1970 |
| Ken Fujioka | GM of Business Administration Department & Director | -- | -- | 1967 |
| Mr. Hiroshi Akitomo | Manager of Development Department and Director | -- | -- | 1961 |
| Hidetoshi Hamamoto | Manager of Research Department and Director | -- | -- | 1969 |
MedRx Co., Ltd
- Sector:
- Healthcare
- Industry: Drug Manufacturers - Specialty & Generic
- Full Time Employees:
- 22
Description
MedRx Co., Ltd, a pharmaceutical formulation development company, provides pharmaceutical drugs based on the transdermal absorption system in Japan. The company develops medicines based on Ionic liquid transdermal system (ILTS) and Nano-sized Colloid Transdermal System (NCTS); and researches and develops painless transdermal administration system for vaccines, nucleic acid medicines, protein medicines, etc. Its products pipeline includes MRX-4TZT, which is in phase I clinical trials for the treatment of spastic paralysis; MRX-9FLT that is in phase I clinical trials to treat chronic, cancer, and severe pain; and MRX-7MLL and MRX-6LDT that is in pre-clinical trials to treat Alzheimer's disease and chronic pain, as well as MRX-5LBT that has completed the clinical trials for the treatment of postherpetic nerve pain. MedRx Co., Ltd was incorporated in 2002 and is headquartered in Higashikagawa, Japan.
Corporate Governance
Upcoming Events
May 9, 2025 at 10:59 AM UTC
MedRx Co., Ltd Earnings Date
Recent Events
Recent Events Information Not Available